389 related articles for article (PubMed ID: 24744147)
1. O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.
Olivier-Van Stichelen S; Dehennaut V; Buzy A; Zachayus JL; Guinez C; Mir AM; El Yazidi-Belkoura I; Copin MC; Boureme D; Loyaux D; Ferrara P; Lefebvre T
FASEB J; 2014 Aug; 28(8):3325-38. PubMed ID: 24744147
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
Harosh-Davidovich SB; Khalaila I
Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
[TBL] [Abstract][Full Text] [Related]
3. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
4. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
5. Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.
Inoue Y; Moriwaki K; Ueda Y; Takeuchi T; Higuchi K; Asahi M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1681-1687. PubMed ID: 29196265
[TBL] [Abstract][Full Text] [Related]
6. The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of β-catenin and cell proliferation.
Olivier-Van Stichelen S; Guinez C; Mir AM; Perez-Cervera Y; Liu C; Michalski JC; Lefebvre T
Am J Physiol Endocrinol Metab; 2012 Feb; 302(4):E417-24. PubMed ID: 22114026
[TBL] [Abstract][Full Text] [Related]
7. Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.
Heath JM; Sun Y; Yuan K; Bradley WE; Litovsky S; Dell'Italia LJ; Chatham JC; Wu H; Chen Y
Circ Res; 2014 Mar; 114(7):1094-102. PubMed ID: 24526702
[TBL] [Abstract][Full Text] [Related]
8. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
9. Dual-specificity RNA aptamers enable manipulation of target-specific O-GlcNAcylation and unveil functions of O-GlcNAc on β-catenin.
Zhu Y; Hart GW
Cell; 2023 Jan; 186(2):428-445.e27. PubMed ID: 36626902
[TBL] [Abstract][Full Text] [Related]
10. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
11. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.
Butkinaree C; Park K; Hart GW
Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786
[TBL] [Abstract][Full Text] [Related]
12. Modulation of O-GlcNAcylation Regulates Autophagy in Cortical Astrocytes.
Rahman MA; Hwang H; Cho Y; Rhim H
Oxid Med Cell Longev; 2019; 2019():6279313. PubMed ID: 31827688
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.
Bolanle IO; Riches-Suman K; Williamson R; Palmer TM
Pharmacol Res; 2021 Mar; 165():105467. PubMed ID: 33515704
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
Copeland RJ; Bullen JW; Hart GW
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E17-28. PubMed ID: 18445751
[TBL] [Abstract][Full Text] [Related]
15. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
16. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
[TBL] [Abstract][Full Text] [Related]
17. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation.
Wang Z; Pandey A; Hart GW
Mol Cell Proteomics; 2007 Aug; 6(8):1365-79. PubMed ID: 17507370
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc modification, insulin signaling and diabetic complications.
Issad T; Masson E; Pagesy P
Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
[TBL] [Abstract][Full Text] [Related]
19. NRAGE induces β-catenin/Arm O-GlcNAcylation and negatively regulates Wnt signaling.
Chen Y; Jin L; Xue B; Jin D; Sun F; Wen C
Biochem Biophys Res Commun; 2017 May; 487(2):433-437. PubMed ID: 28427939
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation of amyloid-β precursor protein at threonine 576 residue regulates trafficking and processing.
Chun YS; Kwon OH; Chung S
Biochem Biophys Res Commun; 2017 Aug; 490(2):486-491. PubMed ID: 28624365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
